Atlas Trials

Safety and Efficacy of Lapatinib Plus Trastuzumab or Lapatinib Plus Capecitabine in Metastatic Breast Cancer

Clinical trial NCT01985893 · WITHDRAWN

Trial details

NCT number
NCT01985893
Sponsor
Berufsverband Niedergelassener Gynäkologischer Onkologen in Deutschland e.V.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2013-09-01
Primary completion
2015-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.